← Back to News

Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents

June 23, 2023

SQP22 uses click chemistry to localize a cancer therapeutic that was previously too toxic to be used in humans (MMAE) to the site of the tumor using antibody binding to HER2.

This is the first demonstration of our ability to use antibody binding to localize our click chemistry technology to the tumor.

Read more here

Want to stay up to date on our news? 
Follow us on LinkedIn